Gregory Zante
Direttore Finanziario/CFO presso VIKING THERAPEUTICS, INC.
Patrimonio netto: 12 M $ in data 30/04/2024
Posizioni attive di Gregory Zante
Società | Posizione | Inizio | Fine |
---|---|---|---|
VIKING THERAPEUTICS, INC. | Direttore Finanziario/CFO | 04/01/2021 | - |
Contatto Relazioni con gli Investitori | - | - | |
Comptroller/Controller/Auditor | 15/02/2021 | - | |
Direttore operativo | 01/12/2016 | 01/08/2019 | |
Public Communications Contact | 05/01/2016 | - | |
Corporate Officer/Principal | 01/08/2019 | 04/01/2021 |
Storia della carriera di Gregory Zante
Precedenti posizioni note di Gregory Zante
Società | Posizione | Inizio | Fine |
---|---|---|---|
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Direttore Finanziario/CFO | 01/01/2013 | 01/01/2016 |
SANGAMO THERAPEUTICS, INC. | Direttore Amministrativo | 01/08/2003 | 01/06/2013 |
Calyx Therapeutics, Inc. | Direttore Amministrativo | 01/12/2001 | - |
Direttore Finanziario/CFO | 01/12/2001 | - | |
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Matrix Pharmaceutical, Inc. is a company that researches and develops pharmaceutical products. The company is based in Fremont, CA. The company was founded in 1985 by Dennis M. Brown. Matrix Pharmaceutical was acquired by Chiron Corp. on February 19, 2002 for $58.63 million. | Corporate Officer/Principal | 01/10/1995 | 01/12/2001 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/10/1993 | 01/11/1995 |
Formazione di Gregory Zante
University of California, Los Angeles | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Posizioni
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 3 |
Chief Administrative Officer | 2 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
VIKING THERAPEUTICS, INC. | Health Technology |
Aziende private | 4 |
---|---|
Calyx Therapeutics, Inc. | |
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Matrix Pharmaceutical, Inc. is a company that researches and develops pharmaceutical products. The company is based in Fremont, CA. The company was founded in 1985 by Dennis M. Brown. Matrix Pharmaceutical was acquired by Chiron Corp. on February 19, 2002 for $58.63 million. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Health Technology |
- Borsa valori
- Insiders
- Gregory Zante
- Esperienza